Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
about
Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerNkx2-1: a novel tumor biomarker of lung cancerCIViC databaseThyroid transcription factors in development, differentiation and diseaseInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaPulmonary adenocarcinoma: a renewed entity in 2011Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis.Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1The lung adenocarcinoma guidelines: what to be considered by surgeons.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.Suppression of lung adenocarcinoma progression by Nkx2-1Thyroid-specific transcription factors and their roles in thyroid cancer.Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.Genetic and biochemical alterations in non-small cell lung cancer.Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China.Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutationsIMP3 can predict aggressive behaviour of lung adenocarcinoma.Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome.Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomasExpression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.The effect of TTF-1 expression on ipsilateral mediastinal nodal (N2) metastases in primary adenocarcinoma of the lungThyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinomaControl of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasisNkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activitiesThe Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients withTargeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway.Lineage factors and differentiation states in lung cancer progression.
P2860
Q24600990-D42119D9-8656-45C0-A38C-D5E10E268AA8Q26995181-0FA7FB9D-0A60-4602-BFA8-1CDDD4B314A6Q27612411-44D42917-3B14-4D28-92B1-ED8581443F60Q28250485-146992A6-E2D9-44A9-8C00-30D529C793A9Q28303718-8B1E7477-B35D-44C6-BBB5-357B24CD0441Q28395348-F51D3698-C407-4DAB-A8A5-6A625892B93CQ33758232-693C554C-1494-4828-9DC5-D4C382DE1000Q33833942-C1F606EB-758E-4D25-87D9-B90731B3D09BQ33925945-5EA2416D-98D3-4A06-85D7-E769DB9D1DA7Q34073818-DBE1F92E-C845-40D1-8DB7-071EC4231776Q34175045-5C95BA82-7D10-43E6-A3FB-29D60E39E40DQ34241853-9DA60952-E2CB-4113-8C5B-0697A8F3C645Q34404201-C1B0411B-AC27-4B88-9B91-CD181B0FAEAEQ34404209-67D54D8F-7791-46F4-A85D-23FEACAB0E40Q34781380-362C3B11-A897-4D9A-BB78-52101E1FF22BQ34794876-3209DDC7-E8AB-498E-BDD6-658032E20B41Q34809743-18BD04A7-034E-465B-8BCB-01A6162FDEBCQ34939788-E952B6A2-67E6-4A41-B09D-ABDA7D9323C2Q35038884-872F24A4-C258-44C7-9FDC-3227427DB9FBQ35632411-4CB6AE89-4340-4E9E-98C7-EBB396BBF057Q36010758-B268E0D7-CBED-45A1-805B-77B464B72F5EQ36013991-DE7F5241-3287-4D1E-8FDF-846F9D07BF98Q36184584-A74C905B-33CB-4BB9-8C66-1662626FAD3CQ36217272-E49FFCC1-14D8-4EB4-8DAC-CAC4E45FD525Q36228469-D7C9CDFD-EE04-4C94-8383-8ADF26266958Q36421052-1F2E7B9C-A889-4626-8C46-593723F14C3EQ36490668-D4195F65-55EF-4C54-A518-1279B7EB0BCCQ36498167-E9175668-3EF5-4CBF-859E-BBEB689C7072Q36592406-07FA50F3-763B-4C1A-B193-30D9D50FFA5AQ36615870-B3B929FC-E24E-4F19-A9E6-EB5C1AFD5103Q36739388-005BB605-E9B8-4819-B9EE-2C5A6DA869CFQ36898402-2D6C1F69-70A3-4696-B004-1C9BD03BCE1BQ36942654-196AF1F3-9990-4E9D-8F0B-4EE4655FC94BQ36952749-160823E9-6719-4EFA-9197-35EB017A77DBQ36971430-E9C3AC4C-5C14-4E42-A9BC-9E32A743CD97Q37041088-5B15C5A0-E74B-4E07-8E34-1AECC510AE5AQ37132018-AFB5F45A-0314-4DE7-97E8-A7E63DE996FDQ37626124-20742701-F8A8-4041-BBCF-BB593DC24442Q37718177-90860DA7-2F72-404A-B829-7955A41B630EQ38395972-81A13677-39D7-47AA-8E88-8C0D3320835D
P2860
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@ast
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@en
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@nl
type
label
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@ast
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@en
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@nl
altLabel
Clinical significance of TTF-1 ...... ication in lung adenocarcinoma
@en
prefLabel
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@ast
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@en
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@nl
P2093
P2860
P50
P1476
Clinical significance of TTF-1 ...... cation in lung adenocarcinoma.
@en
P2093
A John Iafrate
Barbara A Weir
Beow Y Yeap
Bruce E Johnson
Justine A Barletta
Laura A Johnson
Lucian R Chirieac
Sven Perner
William D Travis
P2860
P304
P356
10.1111/J.1582-4934.2008.00594.X
P577
2009-08-01T00:00:00Z